GSKH vs. TMED
GSKH (GSK plc ADRhedged ETF) and TMED (T. Rowe Price Health Care ETF) are both Health & Biotech Equities funds. At a correlation of -0.43, they often move in opposite directions. GSKH charges 0.19%/yr vs 0.44%/yr for TMED.
Performance
GSKH vs. TMED - Performance Comparison
Loading charts...
Returns By Period
GSKH
- 1D
- -0.13%
- 1M
- 4.36%
- YTD
- 9.72%
- 6M
- 9.18%
- 1Y
- 33.80%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GSKH vs. TMED - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
GSKH GSK plc ADRhedged ETF | 5.94% |
TMED T. Rowe Price Health Care ETF | -7.14% |
Correlation
The correlation between GSKH and TMED is -0.43, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 4, 2026 | -0.43 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GSKH vs. TMED — Risk / Return Rank
GSKH
TMED
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
GSKH vs. TMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GSK plc ADRhedged ETF (GSKH) and T. Rowe Price Health Care ETF (TMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GSKH | TMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.22 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.57 | — | — |
| Martin ratioReturn relative to average drawdown | 4.07 | — | — |
Loading charts...
Drawdowns
GSKH vs. TMED - Drawdown Comparison
The maximum GSKH drawdown since its inception was -18.54%, which is greater than TMED's maximum drawdown of -7.14%. Use the drawdown chart below to compare losses from any high point for GSKH and TMED.
Loading charts...
Drawdown Indicators
| GSKH | TMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.54% | -7.14% | -11.40% |
Max Drawdown (1Y)Largest decline over 1 year | -18.54% | — | — |
Current DrawdownCurrent decline from peak | -11.77% | -7.14% | -4.63% |
Average DrawdownAverage peak-to-trough decline | -5.75% | -5.00% | -0.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.84% | — | — |
Volatility
GSKH vs. TMED - Volatility Comparison
Loading charts...
Volatility by Period
| GSKH | TMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.45% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 18.43% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 26.45% | 66.28% | -39.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.00% | 66.28% | -39.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.00% | 66.28% | -39.28% |
GSKH vs. TMED - Expense Ratio Comparison
GSKH has a 0.19% expense ratio, which is lower than TMED's 0.44% expense ratio.
Dividends
GSKH vs. TMED - Dividend Comparison
GSKH's dividend yield for the trailing twelve months is around 1.54%, while TMED has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
GSKH GSK plc ADRhedged ETF | 1.54% | 1.15% |
TMED T. Rowe Price Health Care ETF | 0.00% | 0.00% |
Frequently Asked Questions
GSKH and TMED have a correlation of -0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GSKH is cheaper at 0.19% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GSKH is cheaper with a 0.19% expense ratio, compared with 0.44% for TMED.
GSKH has the higher dividend yield at 1.54%, compared with 0.00% for TMED.
They also come from different issuers: ADRhedged and T. Rowe Price. Their fees differ too: 0.19% for GSKH and 0.44% for TMED.
Find the right allocation for GSKH and TMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer